Akush Ginekol (Sofiia). 2008;47(6):22-5.
Our aim was to evaluate retrospectively for 10 years period, the patients operated for endometrial cancer with or without lymph node dissection.
The patients who entered the research work were mainly from the National Oncological Centre-Sofia, Obstetrics and Gynecological Hospital-Varna and some experience, data and advice from the RHW-Sydney. We evaluated two groups of patients. The first group of 450 patients operated with total abdominal hysterectomy (type II), BSO without lymph node dissection and second group of 450 patients-with radical abdominal hysterectomy, BSO with pelvic and/or paraaortal lymph node dissection.
The results in both groups were evaluated. The median survival follow up was from 3 to 5 years. The patients with pelvic or paraaortal lymph node dissection have statistically significant better overall survival (p-0.0003) and also better survival for the patients with low risk as well as for patients with high risk (for low risk patients--p=0.028; for patients with high risk--p=0.0008).
Our approach differs a little bit from the surgical practice in some clinics with super radicality, where paraaortic lymphadenectomy is more commonly advocated. We do not offer routine paraaortal lymphadenectomy, because of the fact that the presence of paraaortal metastases is very little, when there is a lack of pelvic metastases. According to our data the resection of the bulky paraaortal lymph nodes is enough. The patients with high risk for paraaortal metastases are as follows: patients with bulky positive pelvic lymph nodes; patients with positive enlarged adnexa; patients with grade 2 and 3 and invasion in the outer third of the myometrium.
According to our results and assessing the 3 and 5 years survival rate, the second group of patients (450 patients) in whom pelvic and paraaortal lymph node dissection is performed had statistically better survival rate, as well as better survival for the low risky group and high risky group.
我们旨在对接受或未接受淋巴结清扫术的子宫内膜癌手术患者进行为期10年的回顾性评估。
参与本研究的患者主要来自索菲亚国家肿瘤中心、瓦尔纳妇产科医院,同时借鉴了悉尼皇家妇女医院的一些经验、数据和建议。我们评估了两组患者。第一组450例患者接受了全腹子宫切除术(II型)、双侧输卵管卵巢切除术,未进行淋巴结清扫;第二组450例患者接受了根治性腹式子宫切除术、双侧输卵管卵巢切除术,并进行了盆腔和/或腹主动脉旁淋巴结清扫。
对两组患者的结果进行了评估。中位生存随访时间为3至5年。进行盆腔或腹主动脉旁淋巴结清扫的患者总体生存率在统计学上有显著提高(p = 0.0003),低风险患者和高风险患者的生存率也更高(低风险患者——p = 0.028;高风险患者——p = 0.0008)。
我们的方法与一些主张超根治性手术的临床实践略有不同,在那些临床实践中更常提倡进行腹主动脉旁淋巴结清扫术。我们不提供常规的腹主动脉旁淋巴结清扫术,因为当没有盆腔转移时,腹主动脉旁转移的情况非常少见。根据我们的数据,切除肿大的腹主动脉旁淋巴结就足够了。腹主动脉旁转移高风险的患者如下:盆腔淋巴结肿大阳性的患者;附件肿大阳性的患者;2级和3级且肌层外三分之一受侵的患者。
根据我们的结果并评估3年和5年生存率,进行盆腔和腹主动脉旁淋巴结清扫的第二组患者(450例)在统计学上有更好的生存率,低风险组和高风险组的生存率也更高。